Mark For: THERION BIOLOGICS® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of HIV, cancers, including leukemia, lymphomas, carcinomas, colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma and metastic cancers; vaccines and recombinant vectors of pox and component immune-stimulatory agents used in said vaccines to produce biological immunogens for use in humans. [all]
Status
2022-07-20 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
Yes
Current Use
Yes
Intent To Use
No
Filed ITU
No
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Cancellation Code
2
Attorney Name
CHRISTINE M. BAKER
Attorney Docket Number
09999-523
Law Office Assigned
M60
Employee Name
SOUDERS, MICHAEL J
Timeline
1993-08-19
Date of First Use
1993-08-19
Date of Use In Commerce
2002-06-07
Application Filed
2003-06-24
Published
2003-06-24
Published for Opposition
2003-09-16
Trademark Registered
2007-06-29
Location: SCANNING ON DEMAND
2010-04-24
Cancelled
2010-04-24
Status: Dead/Cancelled
2010-04-24
Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
Christine M. Baker, Esq. MINTZ, LEVIN COHN FERRIS, ET AL 666 Third Avenue New York NY 10017
Good, Services, and Codes
(CANCELLED) IC 005. US 006 018 044 046 051 052. G & S: pharmaceutical preparations for the treatment of HIV, cancers, including leukemia, lymphomas, carcinomas, colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma and metastic cancers; vaccines and recombinant vectors of pox and component immune-stimulatory agents used in said vaccines to produce biological immunogens for use in humans. FIRST USE: 19930819. FIRST USE IN COMMERCE: 19930819(CANCELLED) IC 042. US 100 101. G & S: pharmaceutical research and development. FIRST USE: 19930819. FIRST USE IN COMMERCE: 19930819
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
International Codes:
42
U.S. Codes:
100,101
Type Code
Type
D10000
"BIOLOGICS"
Trademark Filing History
Description
Date
Proceeding Number
CANCELLED SEC. 8 (6-YR)
2010-04-24
CASE FILE IN TICRS
2007-06-29
REGISTERED-PRINCIPAL REGISTER
2003-09-16
TEAS CHANGE OF CORRESPONDENCE RECEIVED
2003-08-13
PUBLISHED FOR OPPOSITION
2003-06-24
NOTICE OF PUBLICATION
2003-06-04
APPROVED FOR PUB - PRINCIPAL REGISTER
2003-04-17
EXAMINERS AMENDMENT MAILED
2003-04-11
PAPER RECEIVED
2003-03-10
CORRESPONDENCE RECEIVED IN LAW OFFICE
2003-03-10
PAPER RECEIVED
2003-02-13
CORRESPONDENCE RECEIVED IN LAW OFFICE
2003-02-13
NON-FINAL ACTION MAILED
2002-09-24
ASSIGNED TO EXAMINER
2002-09-19
76596
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.